Meeder Asset Management Inc Enanta Pharmaceuticals Inc Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $1,014 - $1,496	-21 Reduced 18.92%	90 $5,000
Q2 2022 Aug 08, 2022	SELL	$38.13 - $76.93 $838 - $1,692	-22 Reduced 16.54%	111 $5,000
Q1 2022 May 10, 2022	BUY	$56.06 - $74.11 $7,455 - $9,856	133 New	133 $9,000
Q4 2021 Feb 11, 2022	SELL	$60.19 - $97.37 $6,380 - $10,321	-106 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$41.02 - $58.65 $451 - $645	11 Added 11.58%	106 $6,000
Q2 2021 Aug 09, 2021	SELL	$43.76 - $53.11 $1,750 - $2,124	-40 Reduced 29.63%	95 $4,000
Q1 2021 Apr 28, 2021	SELL	$41.69 - $54.95 $375 - $494	-9 Reduced 6.25%	135 $7,000
Q4 2020 Feb 09, 2021	BUY	$41.16 - $47.47 $246 - $284	6 Added 4.35%	144 $6,000
Q3 2020 Nov 02, 2020	BUY	$43.36 - $53.53 $4,682 - $5,781	108 Added 360.0%	138 $6,000
Q2 2020 Aug 11, 2020	BUY	$46.37 - $57.58 $1,391 - $1,727	30 New	30 $2,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $5,107 - $7,874	-127 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$57.95 - $66.61 $12,922 - $14,854	-223 Reduced 63.71%	127 $8,000
Q3 2019 Oct 17, 2019	SELL	$60.08 - $88.17 $240,800 - $353,385	-4,008 Reduced 91.97%	350 $21,000
Q2 2019 Aug 05, 2019	BUY	$81.3 - $97.35 $255,282 - $305,679	3,140 Added 257.8%	4,358 $368,000
Q1 2019 Apr 16, 2019	SELL	$69.08 - $105.66 $37,095 - $56,739	-537 Reduced 30.6%	1,218 $117,000
Q4 2018 Jan 17, 2019	SELL	$65.41 - $84.65 $6,671 - $8,634	-102 Reduced 5.49%	1,755 $124,000
Q3 2018 Nov 02, 2018	SELL	$85.46 - $126.37 $39,311 - $58,130	-460 Reduced 19.85%	1,857 $0
Q2 2018 Jul 24, 2018	BUY	$81.85 - $120.51 $104,768 - $154,252	1,280 Added 123.43%	2,317 $0
Q1 2018 May 03, 2018	SELL	$57.91 - $92.15 $5,038 - $8,017	-87 Reduced 7.74%	1,037 $85,000
Q4 2017 Feb 02, 2018	BUY	$45.65 - $59.37 $7,943 - $10,330	174 Added 18.32%	1,124 $66,000
Q3 2017 Oct 20, 2017	BUY	$37.91 - $46.8 $36,014 - $44,460	950	950 $45,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$18 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$17 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$15.8 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$12.8 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$9.44 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account